The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
A Framework for Crafting Clinical Practice Guidelines that are Relevant to the Care and Management of People with Multimorbidity
Open accessAbstract
Many patients of all ages have multiple conditions, yet clinicians often lack explicit guidance on how to approach clinical decision-making for such people. Most recommendations from clinical practice guidelines (CPGs) focus on the management of single diseases, and may be harmful or impractical for patients with multimorbidity. A major barrier to the development of guidance for people with multimorbidity stems from the fact that the evidence underlying CPGs derives from studies predominantly focused on the management of a single disease. In this paper, the investigators from the Improving Guidelines for Multimorbid Patients Study Group present consensus-based recommendations for guideline developers to make guidelines more useful for the care of people with multimorbidity. In an iterative process informed by review of key literature and experience, we drafted a list of issues and possible approaches for addressing important coexisting conditions in each step of the guideline development process, with a focus on considering relevant interactions between the conditions, their treatments and their outcomes. The recommended approaches address consideration of coexisting conditions at all major steps in CPG development, from nominating and scoping the topic, commissioning the work group, refining key questions, ranking importance of outcomes, conducting systematic reviews, assessing quality of evidence and applicability, summarizing benefits and harms, to formulating recommendations and grading their strength. The list of issues and recommendations was reviewed and refined iteratively by stakeholders. This framework acknowledges the challenges faced by CPG developers who must make complex judgments in the absence of high-quality or direct evidence. These recommendations require validation through implementation, evaluation and refinement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“In addition to the aforementioned issues with diagnostic error definitions, most clinical practice guidelines target specific diseases, ignoring their relevance for patients with various comorbidities [148,149,150].”
From Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors (2026) · cites this paper as [149]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Self-citationBarnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
Self-citationBoyd, C. M., Darer, J., Boult, C., Fried, L. P., Boult, L., & Wu, A. W. (2005) · JAMA · doi:10.1001/jama.294.6.716 · Cited by 2,581
GRADE guidelines: 2. Framing the question and deciding on important outcomes
Guyatt, G. H., Oxman, A. D., Kunz, R., Atkins, D., Brozek, J., Vist, G., Alderson, P., Glasziou, P., Falck-Ytter, Y., & Schünemann, H. J. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.012 · Cited by 1,911
Self-citationGRADE guidelines: 8. Rating the quality of evidence—indirectness
Guyatt, G. H., Oxman, A. D., Kunz, R., Woodcock, J., Brozek, J., Helfand, M., Alonso-Coello, P., Falck-Ytter, Y., Jaeschke, R., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.04.014 · Cited by 1,843
Self-citationGuyatt, G. H., Akl, E. A., Crowther, M. A., Gutterman, D. D., & Schünemann, H. J. (2012) · CHEST Journal · doi:10.1378/chest.1412s3 · Cited by 1,545
Self-citationPatterns of Functional Decline at the End of Life
Lunney, J. R. (2003) · JAMA · doi:10.1001/jama.289.18.2387 · Cited by 1,418
Kirkman, M. S., Briscoe, V. J., Clark, N., Florez, H., Haas, L. B., Halter, J. B., Huang, E. S., Korytkowski, M. T., Munshi, M. N., Odegard, P. S., et al. (2012) · Diabetes Care · doi:10.2337/dc12-1801 · Cited by 1,274
for the European Depression in Diabetes (EDID) Research Consortium, Nouwen, A., Winkley, K., Twisk, J., Lloyd, C. E., Peyrot, M., Ismail, K., & Pouwer, F. (2010) · Diabetologia · doi:10.1007/s00125-010-1874-x · Cited by 756
Research works printed but not linked: 15
- Patient-centered care for older adults with multiple chronic conditions: a stepwise approach from the american geriatrics society: american geriatrics society expert panel on the care of older adults with multimorbidity. J Am Geriatr Soc. 2012;60(10):1957–68. · DOI
- Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med. 2004;351(27):2870–4. · DOI
- Brown AF, Mangione CM, Saliba D, Sarkisian CA. Guidelines for improving the care of the older person with diabetes mellitus. J Am Geriatr Soc. 2003;51(5 Suppl Guidelines):S265–80.
- Van Spall HG, Toren A, Kiss A, Fowler RA. Eligibility criteria of randomized controlled trials published in high-impact general medical journals: a systematic sampling review. JAMA. 2007;297(11):1233–40. · DOI
- Braithwaite RS, Fiellin D, Justice AC. The payoff time: a flexible framework to help clinicians decide when patients with comorbid disease are not likely to benefit from practice guidelines. Med Care. 2009;47(6):610–7. · DOI
- Institute of Medicine. Clinical Practice Guidelines We Can Trust: The National Academies Press, 2011.
- National Institute for Clinical Excellence. Guideline Development Methods: Information for National Collaborating Centres and Guideline Developers. London: National Institute for Clinical Excellence; 2004. Updated 2005.
- KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis 2007;49(2 Suppl 2):S12–154. · DOI · Paper page
- Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med. 2006;354(4):379–86. · DOI
- KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009(113):S1–130.
- MacLean S, Mulla S, Akl EA, Jankowski M, Vandvik PO, Ebrahim S, et al. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e1S–23S. · DOI
- Butler M, Talley KMC, Burns R, Ripley A, Rothman A, Johnson P, et al. Values of Older Adults Related to Primary and Secondary Prevention. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011.
- Boyd CM, Vollenweider D, Puhan MA. Informing evidence-based decision-making for patients with comorbidity: availability of necessary information in clinical trials for chronic diseases. PLoS One. 2012;7(8):e41601. · DOI
- You JJ, Singer DE, Howard PA, Lane DA, Eckman MH, Fang MC, et al. Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e531S–75S.
- Greenfield S, Billimek J, Pellegrini F, Franciosi M, De Berardis G, Nicolucci A, et al. Comorbidity affects the relationship between glycemic control and cardiovascular outcomes in diabetes: a cohort study. Ann Intern Med. 2009;151(12):854–60. · DOI
Cited by
Sorted by citations
Items 101–139 of 139
Toward Safer Diagnoses: A SEIPS-Based Narrative Review of Diagnostic Errors
Yen, C., Epling, J. W., Rockwell, M., & Vaughn-Cooke, M. (2026) · Diagnostics · doi:10.3390/diagnostics16020347 · Cited by 6
Lim, J., Jeong, S., Jang, S., & Jang, S. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1080703 · Cited by 8
“Adverse health outcomes associated with PIM use should be associated with the number and types of comorbidities in older adults (18, 19), which is usually accounted for as a covariate adjustment, but not taken into full consideration in most studies.”
BackgroundPretorius, S., Bartle, V., Bellass, S., Blackburn, E.-R., Bold, H., Cooper, R., Cordell, H. J., Evison, F., Holding, R., Howe, N., et al. (2026) · BMJ Medicine · doi:10.1136/bmjmed-2025-001495 · Cited by 2
“22 Inclusion of patient representatives in most guideline development groups suggests some attempt to incorporate patient and advocate perspectives, but whether these contributors reflect lived experience of the index condition or of multiple long term conditions more broadly is often unclear.”
Accelerated retinal ageing and multimorbidity in middle-aged and older adults
Chen, R., Zeng, X., Hu, W., Jeyarajan, D., Yu, Z., Wang, W., Ge, Z., Shang, X., He, M., & Zhu, Z. (2025) · GeroScience · doi:10.1007/s11357-025-01581-1 · Cited by 4
“However, as opposed to those with only a single disease, people with multimorbidity experience a poorer quality of life and are higher users of ambulatory and inpatient care [35, 36], which can lead to many undesirable effects [37, 38].”
Recommandations suisses pour le bilan de santé au cabinet médical
Cornuz, J., Auer, R., Neuner-Jehle, S., Humair, J.-P., Jacot-Sadowski, I., Cardinaux, R., Battegay, E., Zeller, A., Zoller, M., Biedermann, A., et al. (2015) · Revue medicale suisse · doi:10.5167/uzh-114078 · Cited by 5
Alterações da ECA2 e Fatores de Risco para Gravidade da COVID-19 em Pacientes com Idade Avançada
Tavares, C. A. M., Avelino‐Silva, T. J., Benard, G., Cardozo, F. A. M., Fernandes, J. R., Girardi, A. C. C., & Filho, W. J. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200487 · Cited by 17
González, R., Mitra, K., Vela, E., Gézsi, A., Paajanen, T. I., Gál, Z., Hullám, G., Mäkinen, H., Nagy, T., Kuokkanen, M., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/53162 · Cited by 6
“In addition, it may facilitate the construction of risk groups that accurately represent probabilities of developing new associated disease conditions [26] susceptible to early prevention.”
Polypharmacy, the Good Prescribing Continuum, and the Ethics of Deprescribing
Gurwitz, J. H., Kapoor, A., & Rochon, P. A. (2018) · Public Policy & Aging Report · doi:10.1093/ppar/pry033 · Cited by 5
Risk Stratification for Older Adults with Myocardial Infarction
Saraf, A. A., & Bell, S. P. (2016) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-016-0493-6 · Cited by 5
Galopin, A., Bouaud, J., Pereira, S., & Séroussi, B. (2015) · Medical Informatics Europe · doi:10.3233/978-1-61499-512-8-344 · Cited by 4
“However, research on the provision of guideline-based decision support for patient with multimorbidity is only beginning.”
BackgroundGuidelines and Perioperative Care of the Elderly
Akhtar, S. (2014) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000033 · Cited by 4
Howe, N., Blackburn, E.-R., Sheppard, A., Pretorius, S., Suklan, J., Bellass, S., Cooper, R., Gallier, S., Sapey, E., Sayer, A. A., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-100270 · Cited by 2
Schäfer, I., Jahns, V., Paucke, V., Lühmann, D., Scherer, M., & Nothacker, J. (2025) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1499333 · Cited by 3
Wyer, P. C. (2018) · European Journal for Person Centered Healthcare · doi:10.5750/ejpch.v6i3.1551 · Cited by 4
“Although attempts are underway on the part of guideline developers and methodologists to define ways of mitigating the dilemma [13], it may take decades for the clinical research enterprise to develop a body of research information that conforms to the reality of clinical practice.”
BackgroundYu, J., Jiang, L.-Y., Chen, Q., Wu, L.-Y., Shao, H., Guo, Y., Tong, Y., & Xu, Z.-J. (2025) · Journal of Primary Care & Community Health · doi:10.1177/21501319251396213 · Cited by 2
“9 For multimorbid patients, the physicians analyze the potential for synergistic benefits when treatments address multiple conditions simultaneously.”
Scherer, M., Burgers, J. S., & the Guidelines International Network Multimorbidity Working Group (2024) · Clinical and Public Health Guidelines · doi:10.1002/gin2.12016 · Cited by 2
Self-citationCardona, M., Craig, L., Jones, M., Byambasuren, O., Obucina, M., Hattingh, L., Clark, J. M., Glasziou, P., & Hoffmann, T. (2022) · Global Heart · doi:10.5334/gh.1142 · Cited by 3
Role of comorbidity in assessment of long-term prognosis after myocardial infarction
Zykov, M., Dyachenko, N. V., & Barbarash, O. (2021) · Medical alphabet · doi:10.33667/2078-5631-2021-29-28-32 · Cited by 2
Chan, E., Johnson, C. B., Liddy, C. E., Keely, E., Gauthier, N., Turek, M. A., Shoki, A., & Archibald, D. (2018) · Digital Health · doi:10.1177/2055207618792140 · Cited by 2
“Investigators have called for guideline writers to consider how multimorbidity influences the ability of PCPs to implement treatment recommendations.(13,14) Our results highlight the importance of efforts to consolidate guidelines across multiple specialities into comprehensive treatment approaches, as has been undert…”
BackgroundFitzgerald, S. P., Bean, N. G., & Ruberu, R. P. (2017) · Journal of Comorbidity · doi:10.15256/joc.2017.7.93 · Cited by 3
Osteoporosis as a Geriatric Syndrome
Colon-Emeric, C. S. (2016) · Springer eBooks · doi:10.1007/978-3-319-25976-5_7 · Cited by 1
Wong, J. J., Chua, T. S. J., & Koh, A. S.-M. (2025) · Journal of Asian Pacific Society of Cardiology · doi:10.15420/japsc.2025.15 · Cited by 1
González, R., Mitra, K., Vela, E., Gézsi, A., Paajanen, T. I., Gál, Z., Hullám, G., Mäkinen, H., Nagy, T., Kuokkanen, M., et al. (2023) · medRxiv · doi:10.1101/2023.09.04.23295005 · Cited by 2
Downer, M. B., & Sinha, S. (2022) · Canadian Geriatrics Journal · doi:10.5770/cgj.25.611 · Cited by 1
“Further, the pervasive lack of standard definitions in multimorbidity research, along with the plethora of combinations of chronic diseases seen in clinical practice, provide a complex public health problem, yet multimorbidity rarely becomes incorporated into clinical practice guidelines.(14) Multimorbidity and COVID-…”
BackgroundПалій, І. Г., & Ткачук, І. В. (2019) · Family Medicine · doi:10.30841/2307-5112.1.2019.172068 · Cited by 1
Tratamiento anticoagulante en pacientes médicos con situaciones clínicas complejas
Ruiz-Ruiz, F. J., Medrano, F. J., Santos‐Lozano, J. M., Rodríguez-Torres, P., Navarro-Puerto, A., & Calderón, E. J. (2018) · Revista Clínica Española · doi:10.1016/j.rce.2018.04.007
On evidence-based medicine - Authors' reply.
Djulbegovic, B., & Guyatt, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32854-4 · Cited by 1
Self-citationMultimorbidität – eine Herausforderung für europäische Gesundheitssysteme
Struckmann, V. (2019) · doi:10.14279/depositonce-8828 · Cited by 1
“Persons with multiple chronic conditions pose a challenge for effective continuous quality improvement systems, as current quality standards mostly address single-diseases [65].”
BackgroundInfluentialVara-Luíz, F., Palma, C., Mascarenhas, P., Tham, T., Arvanitakis, M., Rodríguez-de-Santiago, E., Pedroto, I., Simas, D., Radaelli, F., Camus, M., et al. (2026) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2026.101775
“8 .”
Baneshi, M. R., Dobson, A. J., & Mishra, G. (2026) · Quality of Life Research · doi:10.1007/s11136-026-04262-4
Alsayed, A. R., Al-Darraji, M., Al-Qaiseiah, M., Samara, A., & Al-Bayati, M. (2026) · Technologies · doi:10.3390/technologies14040241
Revolutionizing Multimorbidity Care: A Narrative Review on Artificial Intelligence Applications
Singh, K., Souza, L. A. D., George, R. R., Mourid, M. R., Khedr, M. A., Badawi, A. K. A., Farsakoury, R., Yaseen, L., & Nashwan, A. J. (2026) · Health Science Reports · doi:10.1002/hsr2.71676
Sex as a prognostic factor for mortality in adults with acute symptomatic pulmonary embolism
Tejero, E. J., López‐Alcalde, J., Correa-Pérez, A., Stallings, E., Gil, A. G., del Campo-Albendea, L., Mateos-Haro, M., Fernandez-Felix, B. M., Stallings, R., Díaz, N. Á., et al. (2025) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013835.pub2 · Cited by 6
Pessoa-e-Silva, R., Gonçalves, S. M. C., da Silva, E. D. L., dos Santos, E. F., de Menezes, E. D. S. B., Leão, H., Costa, N., Rêgo, M. D. M. D. M., da Rosa, M. M., Pereira, M., et al. (2024) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e17043.2024
“A avaliação de pacientes com comorbidade deve considerar a interação doença-doença, doença-tratamento e tratamento-tratamento (UHLIG K et al., 2014), e no contexto da infecção pelo novo coronavírus é introduzida uma variável adicional (SANYAOLU A et al., 2020), frequentemente acompanhada de novas…”
Anticoagulant treatment of medical patients with complex clinical conditions
Ruiz-Ruiz, F. J., Medrano, F. J., Santos‐Lozano, J. M., Rodríguez-Torres, P., Navarro-Puerto, A., & Calderón, E. J. (2018) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2018.04.015
Role of Multimorbidity and Patterns of Care in Patients with Acute and Chronic Conditions
Weir, D. L. (2014) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3kw57s3n
Metadata
- Authors
- Uhlig, K., Leff, B., Kent, D., Dy, S., Brunnhuber, K., Burgers, J. S., Greenfield, S., Guyatt, G., High, K., Leipzig, R., Mulrow, C., Schmader, K., Schunemann, H., Walter, L. C., Woodcock, J., & Boyd, C. M.
- Affiliations
- Tufts University (US)
- Johns Hopkins University (US)
- Tufts Medical Center (US)
- BMJ Group (United Kingdom) (GB)
- Dutch College of General Practitioners (NL)
- University of California, Irvine (US)
- McMaster University (CA)
- Wake Forest University Health Sciences (US)
- Icahn School of Medicine at Mount Sinai (US)
- The University of Texas at San Antonio Health Science Center (US)
- Duke Medical Center (US)
- San Francisco VA Medical Center (US)
- University of Cambridge (GB)
- Corresponding author
- Boyd, Cynthia M.
- ORCID
- Venue
- Journal of General Internal Medicine
- Published
- 2014-01-18
- Volume
- 29
- Issue
- 4
- Pages
- 670-679
- ISSN
- 0884-8734 (ISSN-L)
- 1525-1497
- PMC
- PMC3965742
- OpenAlex
- W2146328920
- Cited by
- 158
- References
- 0
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 7 · 2023: 10 · 2022: 12 · 2021: 9 · 2020: 10 · 2019: 18 · 2018: 13 · 2017: 22 · 2016: 18 · 2015: 14 · 2014: 10
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of General Internal Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Robert Wood Johnson Foundation
- John A. Hartford Foundation
- Hartford Foundation for Public Giving
- Atlantic Philanthropies
- Brown University
- Tufts Medical Center
- Johns Hopkins University
- Starr Foundation
- Agency for Healthcare Research and Quality (R21HS017653, R21HS018597, AHRQ R21 HS017653, AHRQ R21 HS018597-01)
- Johns Hopkins Bloomberg School of Public Health
- Medical Research Council (MR/K021796/1, MR/K023187/1)
- Economic and Social Research Council (ES/G007462/1)
- Center for Innovative Medicine
- National Institute on Aging (K23AG032910, K24AG041180, NIA K23 AG032910, P30AG028716)
- National Cancer Institute (R01CA134425)
- Topics
- Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Keywords
- multimorbidity, guideline development, comorbidities, clinical decision-making, guideline applicability, evidence quality assessment, benefit-harm assessment, consensus recommendations, stakeholder engagement
- MeSH terms
- Congresses as Topic, Patient Care, Humans, Comorbidity, Practice Guidelines as Topic, Evidence-Based Medicine, Disease Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
